Independent pharmacies are navigating one of the most complex periods in its history. Reimbursements continue to tighten, workforce shortages persist, and operational burdens increase. And by current estimates, up to 30% of community pharmacies are expected to close in 2026 Journal of the American Pharmacists Association.
To better understand how leaders are responding, NimbleRx convened a roundtable of pharmacy owners operating across diverse markets and models. Kathy Collier, Regional Vice President of Operations for Express Rx, Dared Price, Owner of Graves Drug and Christopher R. Antypas, Owner of Asti’s Pharmacy gave insights that converged around a shared reality: independent pharmacies are under pressure — but their differentiators remain powerful.
